UPH Stock Chart & Stats
€66.50
-€0.50(-0.78%)
At close: 4:00 PM EDT
€66.50
-€0.50(-0.78%)
Day’s Range― - ―
52-Week Range€49.60 - €80.50
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.13B
Enterprise Value€1.71B
Total Cash (Recent Filing)€24.89M
Total Debt (Recent Filing)€385.79M
Price to Earnings (P/E)498.1
Beta0.54
Next Earnings
Nov 10, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding14,922,698
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-2.41
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€83.34Price Target Upside25.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)2.46
Revenue Forecast (FY)€756.18M
Bulls Say, Bears Say
Bulls Say
Operational Volume And Rate GrowthRising patient volumes alongside higher revenue per visit indicates improving clinic utilization and reimbursement realization. The company’s record activity over multiple consecutive months supports a durable operating trend that can strengthen revenue generation and leverage the existing clinic platform.
Hospital Affiliations And AcquisitionsHospital affiliations and tuck-in acquisitions expand USPH’s clinic footprint and create additional revenue channels through greater scale. The expected contribution from remaining integrations and the active partnership pipeline could support sustained growth beyond the current quarter as onboarding costs fade.
Cash Generation And Financial FlexibilitySolid operating and free cash flow provide resources for acquisitions, clinic investment, and ongoing obligations without relying solely on external capital. Combined with expanded credit availability, this gives USPH meaningful flexibility to pursue growth while maintaining liquidity.
Bears Say
Revenue And Profitability CompressionThe recent decline in revenue and thin profitability indicate that USPH is not currently converting its operating platform into strong earnings. Persistently weak margins can reduce internal funding capacity, limit returns on invested capital, and make future growth more dependent on successful execution.
Higher Operating Cost PressureCost inflation and implementation spending are absorbing part of the benefit from higher volumes and rates. Although some expenses may be associated with expansion, sustained pressure on salaries, benefits, and rollout costs could delay margin recovery and weaken earnings quality over the next several quarters.
Higher Borrowings And Reduced CashThe increase in borrowings alongside lower cash reduces balance-sheet flexibility compared with the prior year and raises the financial burden supporting expansion. Greater leverage can constrain capital allocation if cash generation softens or integration spending remains elevated.
US Physical Therapy News
UPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was €49.60 and its highest was €80.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is €1.13B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Nov 10, 2026 which is in 29 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on Aug 05, 2026. The company reported €0.669 earnings per share for the quarter, missing the consensus estimate of €0.726 by -€0.057.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy does not currently pay dividends.
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.68.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 14,922,698 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of €0.669 in its last earnings report, missing expectations of €0.726. Following the earnings report the stock price went up 1.527%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in DE:UPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€83.34 (25.32% Upside)
€83.34 (25.32% Upside)
Blogger Sentiment
Neutral
DE:UPH Sentiment 80%
Sector Average 67%
Sector Average 67%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.25%
12-Months-Change
Fundamentals
Return on Equity
-1.27%
Trailing 12-Months
Asset Growth
5.87%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.
UPH Company Deck
UPH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call portrays strong operational momentum — solid revenue growth, record visit volumes, improving revenue per visit, active M&A and an expanding hospital-affiliation pipeline that management expects will materially lift results in late 2023 and 2027. Near-term profitability was pressured by elevated employee self-insured medical costs, front-loaded hiring for hospital rollouts and integration costs, leading to margin compression, lower net income and EPS. Management reaffirmed full-year adjusted EBITDA guidance and highlighted meaningful upside from ongoing hospital affiliations and rate increases, indicating confidence in future performance.View all DE:UPH earnings summariesUPH Stock 12 Month Forecast
Average Price Target
€83.34
▲(25.32% Upside)
Technical Analysis
Encompass Health
―
National Healthcare
―
The Ensign Group
―
Pennant Group
―
Concentra Group Holdings Parent, Inc.
―